Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United States
  4. Nasdaq
  5. Moderna, Inc.
  6. News
  7. Summary
    MRNA   US60770K1079

MODERNA, INC.

(MRNA)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Canadian dollar dips as virus variant risk offsets GDP gain

11/30/2021 | 09:37am EST
FILE PHOTO: A Canadian dollar coin, commonly known as the

TORONTO (Reuters) - The Canadian dollar weakened against its U.S. counterpart on Tuesday as fears that the Omicron coronavirus variant could impede global economic recovery offset data showing stronger than expected growth in the domestic economy.

World share markets dropped after the CEO of drugmaker Moderna warned that COVID-19 vaccines are unlikely to be as effective against the new variant.

Canada is a major producer of commodities, including oil, so the loonie tends to be sensitive to prospects for global growth.

U.S. crude oil futures fell nearly 4% to $67.23, while the Canadian dollar was trading 0.2% lower at 1.2767 to the greenback, or 78.33 U.S. cents.

The currency touched its weakest intraday level since Sept. 22 at 1.2812.

Canada's economy grew 5.4% in the third quarter on an annualized basis, beating analyst expectations for a gain of 3.0%, Statistics Canada data showed.

A preliminary estimate for October showed a gain of 0.8%, while September's GDP was in line with expectations for a 0.1% rise.

Canadian government bond yields were lower across a flatter curve, tracking the move in U.S. Treasuries.

The 10-year rate hit its lowest intraday level since Oct. 14 at 1.534% before recovering slightly to 1.546%, down 6.8 basis points on the day.

(Reporting by Fergal Smith; Editing by Nick Zieminski)


ę Reuters 2021
All news about MODERNA, INC.
07:44aOMICRON-SPECIFIC VACCINE LIKELY TO C : Sharma
AQ
01/14INSIDER SELL : Moderna
MT
01/14Denver International Airport to Host COVID-19 Vaccine Booster Clinics for Employees and..
AQ
01/14Uganda to Destroy 400,000 Covid-19 Vaccines That Are Due to Expire
AQ
01/13Health Care Down Amid Valuation Concerns -- Health Care Roundup
DJ
01/13Today on Wall Street: Time for a new chapter?
01/13EUROPEAN MIDDAY BRIEFING - Stocks Down, Investors -2-
DJ
01/13WHO, EMA Warn Against Repeated COVID-19 Booster Shots
MT
01/13New data finds AstraZeneca booster generates higher antibodies against Omicron
RE
01/13Moderna Expects to Report Vaccine Data for Young Children in March
DJ
More news
Analyst Recommendations on MODERNA, INC.
More recommendations
Financials (USD)
Sales 2021 17 480 M - -
Net income 2021 11 079 M - -
Net cash 2021 9 706 M - -
P/E ratio 2021 7,75x
Yield 2021 -
Capitalization 83 008 M 83 008 M -
EV / Sales 2021 4,19x
EV / Sales 2022 2,97x
Nbr of Employees 1 300
Free-Float -
Chart MODERNA, INC.
Duration : Period :
Moderna, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends MODERNA, INC.
Short TermMid-TermLong Term
TrendsBearishBearishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 19
Last Close Price 204,73 $
Average target price 273,06 $
Spread / Average Target 33,4%
EPS Revisions
Managers and Directors
StÚphane Bancel Chief Executive Officer & Director
Stephen Hoge President
David W. Meline Chief Financial Officer
Noubar B. Afeyan Chairman
Juan Andres Chief Technical Operations & Quality Officer
Sector and Competitors
1st jan.Capi. (M$)
MODERNA, INC.-19.39%83 008
LONZA GROUP AG-15.15%52 584
IQVIA HOLDINGS INC.-12.33%47 252
SEAGEN INC.-11.33%25 068
ICON PUBLIC LIMITED COMPANY-13.98%21 684
CELLTRION, INC.-13.64%20 026